TetraLogic Pharmaceuticals Corporation
TLOG
$0.00
$0.000.00%
OTC PK
| 09/30/2016 | 06/30/2016 | 03/31/2016 | 12/31/2015 | 09/30/2015 | |
|---|---|---|---|---|---|
| Net Income | -8.63M | -6.75M | -11.07M | -14.27M | -10.90M |
| Total Depreciation and Amortization | 9.30K | 21.40K | 73.40K | 48.30K | 48.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.85M | 2.53M | 2.85M | 5.02M | 2.85M |
| Change in Net Operating Assets | 983.10K | -1.67M | 2.11M | 7.40K | 321.20K |
| Cash from Operations | -2.79M | -5.86M | -6.03M | -9.19M | -7.68M |
| Capital Expenditure | -- | -- | -- | -700.00 | -26.20K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 152.80K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 5.11M | 8.52M | 8.72M |
| Cash from Investing | 0.00 | 0.00 | 5.26M | 8.52M | 8.70M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | -- | -- | -- | 0.00 | 2.59M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | 0.00 | 2.59M |
| Foreign Exchange rate Adjustments | 4.10K | -3.50K | 10.60K | 67.30K | -133.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.79M | -5.87M | -760.70K | -607.40K | 3.47M |